29 research outputs found
Radiographic researches in radioecological monitoring
The possibilities of one of the radiographic methods - the method of fission-fragment radiography for evaluation of radiographic condition of territories, which are characterized by different source of man-caused and natural radiating loading, are considere
ΠΠ°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠ΅ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΡ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΏΡΠΈ ΡΠ½Π΄ΠΎΠΏΡΠΎΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΠ°Π·ΠΎΠ±Π΅Π΄ΡΠ΅Π½Π½ΡΡ ΡΡΡΡΠ°Π²ΠΎΠ² Π½Π° ΡΠΎΠ½Π΅ ΠΏΡΠΈΠ΅ΠΌΠ° ΠΏΠ΅ΡΠΎΡΠ°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»ΡΠ½ΡΠΎΠ²
Introduction. Direct oral anticoagulants (DOAC) rivaroxaban and apixaban have significantly reduced the risk of developing venous thromboembolic complications (VTEC). However, the use of DOAC may be associated with a higher risk of bleeding, especially actual in patients after total hip arthroplasty (THA).Material and methods. We enrolled 38 patients with moderate osteoarthritis of the hip joints undergoing THA. The mean age of patients was 58 (33; 85) years. All the patients received rivaroxaban or apixaban in the doses specified by Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications (VTEC). Retrospectively, in the postoperative period, the patients were divided into two groups: Group 1 β 31 patients (20 women and 11 men), who had no hemorrhagic complications after hip replacement; and Group 2 β 7 patients (4 women and 3 men) who experienced hemorrhagic events in the form of hematomas in the wound area. Laboratory tests were performed for all patient baseline (1st day of hospitalization), after surgery (1st day after THA), and on the 7th day after THA. Analyses included the determination of hemostasis parameters (INR, aPPT, fibrinogen, D-dimer), hematological (HGB, PLT, RBC) and biochemical parameters (calcium, ionized calcium, serum iron, hs-CRP).Results. The analysis of biochemical parameters in patients with hemorrhagic complications revealed a significant increase of fibrinogen (p=0,023) compared with uncomplicated cases. Serum iron concentration in men with hemorrhagic complications in the postoperative period was significantly lower than in patients without complications. In patients with hemorrhagic complications, the ionized calcium was lower (p=0,032) than in patients without complications, but within the reference values. The hs-CRP concentration in the group with hemorrhagic complications was twice higher than in the group without complication and eight times above the reference values.Conclusion. The concentration of iron in the blood serum in men below 11 mmol/l and a slight hyperfibrinogenemia of 4.65 g/l in all the patients are the risks of developing hematomas in the area of surgery. These parameters should be used to predict the risk of hemorrhagic complications in patients before THA and recommended for control before the surgery and on the 1st day after THA (hs-CRP).ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΏΡΡΠΌΡΠ΅ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠ²Π΅ΡΡΡΠ²Π°Π½ΠΈΡ ΠΊΡΠΎΠ²ΠΈ Π΄Π»Ρ ΠΏΠ΅ΡΠΎΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠ΅ΠΌΠ° (ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½ ΠΈ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½) ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ½ΠΈΠ·ΠΈΡΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π²Π΅Π½ΠΎΠ·Π½ΡΡ
ΡΡΠΎΠΌΠ±ΠΎΡΠΌΠ±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ (ΠΠ’ΠΠ). ΠΠ΄Π½Π°ΠΊΠΎ Π² ΡΡΠ΄Π΅ ΡΠ»ΡΡΠ°Π΅Π² Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎ ΡΠΊΡΡΡΡΠΌΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌΠΈ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π° ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡΡΠΌΡΡ
ΠΏΠ΅ΡΠΎΡΠ°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΠΊΠΎΠ°Π³ΡΠ»ΡΠ½ΡΠΎΠ² ΠΌΠΎΠΆΠ΅Ρ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ Π°ΡΡΡΠΎΠΏΠ»Π°ΡΡΠΈΠΊΠΈ ΡΠ°Π·ΠΎΠ±Π΅Π΄ΡΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ 38 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΡΡΠ΅ΠΎΠ°ΡΡΡΠΈΡΠΎΠΌ ΡΠ°Π·ΠΎΠ±Π΅Π΄ΡΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π° III ΡΡ., ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠ΅ ΡΠΎΡΠ°Π»ΡΠ½ΠΎΠ΅ ΡΠ½Π΄ΠΎΠΏΡΠΎΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ°Π·ΠΎΠ±Π΅Π΄ΡΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π°. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎΡΡΠ°Π²Π»ΡΠ» 58 (33; 85) Π»Π΅Ρ. ΠΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½ ΠΈΠ»ΠΈ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½ Π² Π΄ΠΎΠ·Π°Ρ
, ΡΠΊΠ°Π·Π°Π½Π½ΡΡ
Π ΠΎΡΡΠΈΠΉΡΠΊΠΈΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌΠΈ ΠΏΠΎ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅, Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΠ’ΠΠ. Π Π΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎ Π² ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: 1-Ρ Π³ΡΡΠΏΠΏΠ° β 31 ΠΏΠ°ΡΠΈΠ΅Π½Ρ (20 ΠΆΠ΅Π½ΡΠΈΠ½ ΠΈ 11 ΠΌΡΠΆΡΠΈΠ½), Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΏΠΎΡΠ»Π΅ ΡΠ½Π΄ΠΎΠΏΡΠΎΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ°Π·ΠΎΠ±Π΅Π΄ΡΠ΅Π½Π½ΡΡ
ΡΡΡΡΠ°Π²ΠΎΠ² Π½Π΅ Π±ΡΠ»ΠΎ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, ΠΈ 2-Ρ Π³ΡΡΠΏΠΏΠ° β 7 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (4 ΠΆΠ΅Π½ΡΠΈΠ½Ρ ΠΈ 3 ΠΌΡΠΆΡΠΈΠ½), Ρ ΠΊΠΎΡΠΎΡΡΡ
Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈΡΡ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΎΠ±ΡΡΠΈΡ Π² Π²ΠΈΠ΄Π΅ Π³Π΅ΠΌΠ°ΡΠΎΠΌ Π² ΠΎΠ±Π»Π°ΡΡΠΈ ΡΠ°Π½Ρ. ΠΡΠ΅ΠΌ Π±ΠΎΠ»ΡΠ½ΡΠΌ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Ρ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΎ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, Π½Π° ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΈ 10-Π΅ ΡΡΡΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ Π°ΡΡΡΠΎΠΏΠ»Π°ΡΡΠΈΠΊΠΈ. ΠΠ°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ°Π»ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π° (ΠΌΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΠΎΠ΅ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅, Π°ΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠ΅ ΡΡΠΎΠΌΠ±ΠΎΠΏΠ»Π°ΡΡΠΈΠ½ΠΎΠ²ΠΎΠ΅ Π²ΡΠ΅ΠΌΡ, ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½, D-Π΄ΠΈΠΌΠ΅Ρ) ΠΈ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
(ΡΡΠΎΠ²Π½ΠΈ Π² ΠΊΡΠΎΠ²ΠΈ ΠΊΠ°Π»ΡΡΠΈΡ ΠΎΠ±ΡΠ΅Π³ΠΎ, ΠΊΠ°Π»ΡΡΠΈΡ ΠΈΠΎΠ½ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ, ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΆΠ΅Π»Π΅Π·Π°, Π‘-ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° (Π‘Π Π), ΠΊΡΠ΅Π°ΡΠΈΠ½ΠΈΠ½Π°), Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
(ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ², ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ²) ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΡΠΈΠ²Π°ΡΠΎΠΊΡΠ°Π±Π°Π½Π° ΠΈΠ»ΠΈ Π°ΠΏΠΈΠΊΡΠ°Π±Π°Π½Π° Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΒ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. ΠΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ Π±ΡΠ»ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΎ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π² ΠΊΡΠΎΠ²ΠΈ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½Π° (Ρ=0,023) ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠΎ ΡΠ»ΡΡΠ°ΡΠΌΠΈ Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΆΠ΅Π»Π΅Π·Π° Ρ ΠΌΡΠΆΡΠΈΠ½ Ρ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ Π² ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±ΡΠ»Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π½ΠΈΠΆΠ΅, ΡΠ΅ΠΌ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±Π΅Π· ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ. ΠΠΎΠ½ΡΡΠ°ΡΠΈΡΠΎΠ²Π°Π½Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΡΡΠΎΠ²Π½Π΅ ΠΈΠΎΠ½ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΊΠ°Π»ΡΡΠΈΡ (Ca2+). Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ Ca2+ Π±ΡΠ»Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π½ΠΈΠΆΠ΅ (Ρ=0,032), ΡΠ΅ΠΌ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±Π΅Π· ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, Π½ΠΎ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
ΡΠ΅ΡΠ΅ΡΠ΅Π½ΡΠ½ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ Π‘Π Π Π±ΡΠ»Π° Π² 2 ΡΠ°Π·Π° Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² Π³ΡΡΠΏΠΏΠ΅ Π±Π΅Π· ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ Π² 8 ΡΠ°Π· Π²ΡΡΠ΅ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΡΠ΅ΡΠ΅ΡΠ΅Π½ΡΠ½ΡΠΌΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΡΠΌΠΈ.ΠΡΠ²ΠΎΠ΄Ρ. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΆΠ΅Π»Π΅Π·Π° Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ Ρ ΠΌΡΠΆΡΠΈΠ½ Π½ΠΈΠΆΠ΅ 11 ΠΌΠΊΠΌΠΎΠ»Ρ/Π» ΠΈ Π½Π΅Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½Π΅ΠΌΠΈΡ ΡΠ²Π»ΡΡΡΡΡ ΡΠΈΡΠΊΠ°ΠΌΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³Π΅ΠΌΠ°ΡΠΎΠΌ Π² Π·ΠΎΠ½Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ. ΠΠ°Π½Π½ΡΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΌΠΎΠ³ΡΡ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π΄Π»Ρ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΡΠΎΠΏΠ΅Π΄ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ, ΠΊΠΎΡΠΎΡΡΠ΅ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΠΎΠ²Π°ΡΡ Π² ΠΊΡΠΎΠ²ΠΈ ΠΏΠ΅ΡΠ΅Π΄ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ΅ΠΉ (ΡΡΠΎΠ²Π΅Π½Ρ ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΆΠ΅Π»Π΅Π·Π° Ρ ΠΌΡΠΆΡΠΈΠ½ ΠΈ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ³Π΅Π½Π°) ΠΈ Π² ΠΏΠ΅ΡΠ²ΡΠΉ Π΄Π΅Π½Ρ ΠΏΠΎΡΠ»Π΅ Π½Π΅Π΅ (ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π‘Π Π)
FEATURES DIAGNOSTIC FINDING IN DERMATOMYOSITIS (CLINICAL OBSERVATION)
In connection with the polymorphism of clinical manifestations of dermatomyositis, patients in the onset of the disease can apply to doctors of any specialty. However, the statement of this diagnosis causes considerable difficulties for practical doctors who do not work in the field of rheumatology. To a large extent this is due to the fact that inflammation of the muscle tissue can have not only an autoimmune origin, but also be observed with a variety of infections and intoxications. Diagnosis of dermatomyositis is associated with the need to eliminate tumor processes in the body, accompanying it in 20% of cases. The article presents a clinical case of subacute dermatomyositis, which occurred in a man 49 years after massive insolation against the background of photosensitization with fluoroquinolones in the treatment of prostatitis. After detecting a significant increase in the level of serum βmuscleβ enzymes and electromyographic signs of inflammatory myopathy, a patient with characteristic progressive symmetrical muscle weakness of the proximal limb and skin changes was diagnosed with primary idiopathic dermatomyositis withΒ the activity of III degree. Diagnostic search required the exclusion of infectious and neoplastic diseases. Timely formulation of the diagnosis made it possible in time to prescribe immunosuppressive therapy with glucocorticosteroids, achieving a decrease in the activity of the disease and improving the prognosis
Digital Horizons in Teacher Education Development
Modern global challenges reflect the essential features of the Fourth Industrial Revolution and are directly related to the digital transformation of life. The teachers are obliged to master the relevant competences to meet the challenges, as their teaching practices experience significant transformations through the enrichment with the digital component. The current problems in the education system transformation force the researchers to identify the principle transformation characteristics, acquire some new types of pedagogical action and design new teacher education formats. The paper presents the authorsβ vision of the new teacher education formats at the target, organizational, activity and technological levels. The authors analyze the regional experience of modernization in the higher pedagogical education on the basis of Federal Standards in Higher Education 3++ at the bachelor and master program levels. The realization experience of the federal project βModern Digital Educational Environment in the Russian Federationβ as a part of the national project βEducationβ is conceptualized in terms of professional skill enhancement of pedagogical personnel in the Tomsk region. The authors reflect on the development trend of the region research and academic complex in the concept of cooperation and resource consolidation for the βBig Universityβ model. The guidelines for strategic development of Tomsk State Pedagogical University, associated with its digitalization, are outlined. The paper shows the development conditions in the digital transformation of the national system for continuous pedagogical education. The paper materials are based on such research methods as theoretical analysis, expert method, and survey
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΉΠΎΠ΄Π°Π½ΡΠΈΠΏΠΈΡΠΈΠ½Π° ΠΊΠ°ΠΊ ΡΡΠ΅Π΄ΡΡΠ²Π° ΡΠΊΡΡΡΠ΅Π½Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΊΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΈΡΠ°
Jodantipyrin is an antiviral medicament, inductor of endogenous interferon. It relates to the group of nonsteroidal antiinflammatory medicaments of pyrazolone derivative. The principal mechanism of Jodantipyrin antiviral effect is its ability to induce endogenous interferons of the 1 st and 2 nd types, what has been confirmed by the results of numerous and detailed preclinical and clinical trials. At the present time a long-term experience of this medicament application as a prophylactic agent in case of tick-borne encephalitis and data of postmarketing monitoring of the medicament safety have been accumulated. This experience confirms efficacy of the medicament in prophylaxis of tick-borne encephalitis.ΠΠΎΠ΄Π°Π½ΡΠΈΠΏΠΈΡΠΈΠ½ - ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΡΠΉ ΠΏΡΠ΅ΠΏΠ°ΡΠ°Ρ, ΠΈΠ½Π΄ΡΠΊΡΠΎΡ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π°. ΠΡΠ½ΠΎΡΠΈΡΡΡ ΠΊ Π³ΡΡΠΏΠΏΠ΅ Π½Π΅ΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΡ
ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ
ΠΏΠΈΡΠ°Π·ΠΎΠ»ΠΎΠ½Π°. ΠΡΠ½ΠΎΠ²Π½ΡΠΌ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠΌ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΉΠΎΠ΄Π°Π½ΡΠΈΠΏΠΈΡΠΈΠ½Π° ΡΠ²Π»ΡΠ΅ΡΡΡ Π΅Π³ΠΎ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°ΡΡ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΡΠ΅ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Ρ I ΠΈ II ΡΠΈΠΏΠ°, ΡΡΠΎ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
ΠΈ Π΄Π΅ΡΠ°Π»ΡΠ½ΡΡ
Π΄ΠΎΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ ΠΌΠ½ΠΎΠ³ΠΎΠ»Π΅ΡΠ½ΠΈΠΉ ΠΎΠΏΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ΅Π΄ΡΡΠ²Π° ΠΏΡΠΈ ΠΊΠ»Π΅ΡΠ΅Π²ΠΎΠΌ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΈΡΠ΅ ΠΈ Π΄Π°Π½Π½ΡΠ΅ ΠΏΠΎΡΡΠΌΠ°ΡΠΊΠ΅ΡΠΈΠ½Π³ΠΎΠ²ΠΎΠ³ΠΎ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° Π΅Π³ΠΎ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ. ΠΡΠΎΡ ΠΎΠΏΡΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°Π΅Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΉΠΎΠ΄Π°Π½ΡΠΈΠΏΠΈΡΠΈΠ½Π° Π² ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΊΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΈΡΠ°